Studies have demonstrated that AT-secreted TNF-α and IL-6 promote IR and exacerbate NAFLD progression by upregulating the expression of suppressor of cytokine signaling 3 (SOCS3) (Tilg and Moschen, 2010). This evidence concerns the gene IL6 and metabolic dysfunction-associated steatotic liver disease.